S. Tabruyn

发表

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB.

J. Martial, V. Bours, F. Rentier-Delrue, 2003, Molecular endocrinology.

The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation

J. Martial, S. Blacher, S. Herkenne, 2011, PloS one.

MiR-205 is a novel biomarker for hereditary hemorrhagic telangiectasia with antiangiogenic function

I. Struman, C. Bernabéu, L. Botella, 2013 .

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

J. Martial, I. Struman, C. Bernabéu, 2013, Angiogenesis.

Angiogenesis pre print version 1 MiR205 MiR205 MiR205 is a novel biomarker for hereditary hemorrhagic telangiectasia with antiangiogenic function

J. Martial, I. Struman, C. Bernabéu, 2013 .

Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis

M. Tenan, S. Mandriota, A. Sappino, 2020, International journal of molecular sciences.

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

J. Martial, I. Struman, C. Sabatel, 2010, Molecular Cancer.

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

J. Foidart, A. Noël, J. Martial, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells.

V. Bours, A. Griffioen, C. Oury, 2007, Biochemical and biophysical research communications.

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

P. Carmeliet, J. Martial, A. Gils, 2014, Nature Medicine.

Raloxifene-Induced Myeloma Cell Apoptosis: A Study of Nuclear Factor-κB Inhibition and Gene Expression Signature

M. Merville, V. Bours, L. de Leval, 2006, Molecular Pharmacology.

The cancer-specific lncRNA LISR customizes ribosomes to suppress anti-tumour immunity

T. Bonaldi, A. Cuomo, Vicky Katopodi, 2023, bioRxiv.

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.

J. Martial, P. Kelly, G. Bolbach, 2004, Molecular endocrinology.

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

A. Noël, J. Martial, V. Bours, 2015, Oncotarget.

Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.

Barbara Sennino, J. Christensen, W. You, 2012, Cancer discovery.

A new role for NF-κB in angiogenesis inhibition

A. Griffioen, S. Tabruyn, 2007, Cell Death and Differentiation.

Molecular pathways of angiogenesis inhibition.

A. Griffioen, S. Tabruyn, 2007, Biochemical and biophysical research communications.

CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.

M. Dyer, P. Schneider, M. Callanan, 2017, Cancer research.

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5

J. Moreaux, M. De Grandis, M. Aurrand-Lions, 2021, Blood advances.

Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors.

C. Kuo, D. McDonald, B. Sennino, 2009, Cancer research.

Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.

V. Bours, C. Oury, A. Vanderplasschen, 2007, Biochemical pharmacology.

miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization

E. Bandrés, F. Lecanda, D. Luis-Ravelo, 2014, Molecular oncology.

GATA2 is required for lymphatic vessel valve development and maintenance.

G. Secker, David M. Lawrence, J. Matthews, 2015, The Journal of clinical investigation.

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.

J. Martial, I. Struman, A. Cornet, 2005, Molecular endocrinology.

Angiostatic activity of the antitumor cytokine interleukin-21.

W. Leonard, A. Griffioen, J. V. van Beijnum, 2008, Blood.

GATA2 is required for lymphatic vessel valve development and maintenance.

G. Secker, David M. Lawrence, J. Matthews, 2015, The Journal of clinical investigation.

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

K. Sliwa, V. Lambert, J. Martial, 2013, The Journal of clinical investigation.

NF-κB: a new player in angiostatic therapy

A. Griffioen, S. Tabruyn, 2008, Angiogenesis.

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.

F. Garnache-Ottou, M. Deschamps, E. Deconinck, 2018, Cancer research.

GSK3732394: a Multi-specific Inhibitor of HIV Entry

D. Langley, P. Nef, M. Krystal, 2019, Journal of Virology.

Prolactin/growth hormone–derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis

R. Brasseur, J. Martial, L. Lins, 2006, Proceedings of the National Academy of Sciences.

Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System

Rémi H. J. Dulize, M. Peitsch, A. Sewer, 2023, International journal of molecular sciences.

NF-κB activation in endothelial cells is critical for the activity of angiostatic agents

J. Martial, A. Griffioen, K. Mayo, 2009, Molecular Cancer Therapeutics.

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation.

Shaun O'Brien, Gou Young Koh, D. McDonald, 2011, The American journal of pathology.

Angiopoietin-2-driven vascular remodeling in airway inflammation.

D. McDonald, G. Thurston, S. Wiegand, 2010, The American journal of pathology.

Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation.

C. Kuo, D. McDonald, G. Thurston, 2010, The American journal of pathology.

Abstract A13: Reduction of tumor invasiveness and metastasis and prolongation of survival of RIP‐Tag2 mice after inhibition of VEGFR plus c‐Met by XL184

W. You, D. McDonald, B. Sennino, 2009 .

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

D. Altschuh, A. Griffioen, R. Meloen, 2016, Proceedings of the National Academy of Sciences.

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation.

J. Martial, A. Griffioen, I. Struman, 2007, Molecular endocrinology.

The angiostatic 16 K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via NF-κ B activation

J. Martial, A. Griffioen, I. Struman, 2009 .

A new role for NF-kappaB in angiogenesis inhibition.

A. Griffioen, S. Tabruyn, 2007, Cell death and differentiation.